RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 70 filers reported holding RA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $147,000 | +2.1% | 3,058 | 0.0% | 0.01% | +33.3% |
| Q4 2019 | $144,000 | +125.0% | 3,058 | +13.3% | 0.01% | +100.0% |
| Q3 2019 | $64,000 | -21.0% | 2,700 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $81,000 | +131.4% | 2,700 | +74.1% | 0.00% | +100.0% |
| Q1 2019 | $35,000 | +59.1% | 1,551 | +29.8% | 0.00% | +100.0% |
| Q4 2018 | $22,000 | +69.2% | 1,195 | +67.1% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | +85.7% | 715 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +75.0% | 715 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | -33.3% | 715 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -40.0% | 715 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -23.1% | 715 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $13,000 | -13.3% | 715 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $15,000 | – | 715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|